Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis

NCT04857489 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT04857489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04857489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapse remitting multiple sclerosis